查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1847859

动物寄生虫杀虫剂市场（按类型、动物种类、应用、寄生虫种类、分销管道和最终用户划分）—2025-2032 年全球预测

Veterinary Parasiticides Market by Type, Animal Type, Mode Of Application, Parasite Type, Distribution Channel, End-User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，动物寄生虫杀虫剂市场规模将成长至 151.8 亿美元，复合年增长率为 7.98%。

主要市场统计数据
基准年2024年 82.1亿美元
预计2025年 88.3亿美元
预测年份：2032年 151.8亿美元
复合年增长率（%） 7.98%

简要介绍受动物健康优先事项、监管强度和技术动力影响的现代兽医寄生虫杀灭剂领域

全球兽医驱虫药领域正处于动物福利期望、不断发展的监管标准和加速的科技创新的交汇点。近年来，伴侣动物和畜牧业的相关人员已将有效的寄生虫控製作为健康管理、生产力和「同一个健康」管理的基石。随着宠物饲养模式的改变、畜牧生产系统的现代化以及人们对将动物寄生虫负担与更广泛的公共卫生结果联繫起来的通用风险的认识不断提高，这一重点也得到了加强。

监管机构和日益成熟的兽医界对下一代化学品、生技药品和输送系统的投资日益严格，对安全性、有效性和永续性的要求也日益提高。同时，该行业正在适应供应链重组、数位化分销管道以及数据主导的动物保健服务日益增长的作用。这些因素共同为製造商、经销商和兽医专业人士带来了挑战和机会，使他们在应对成本压力和抗药性管理需求的同时，满足日益增长的期望。

鑑于这一动态背景，管理者和从业者需要清晰、基于证据地综合技术发展轨迹、监管讯号和商业性路径。仔细评估这些因素将有助于做出明智的决策，包括产品系列、策略伙伴关係以及创新投资，从而带来可衡量的动物用药品成果和可持续的竞争优势。

由于技术创新、分销方式的演变和管理压力，杀寄生虫剂的研究、商业化和生命週期策略正在发生怎样的变化

从发现平台到终端用户交互，兽医驱虫剂领域正在经历多个层面的变革。分子生物学和标靶筛检的进步加速了新型作用机制的识别，而製剂科学则实现了缓释性、减重和精准给药。这些创新与数位化工具相辅相成，这些工具可以提高治疗依从性，实现动物健康的远端监控，并支持数据驱动的抗药性监测。

同时，该行业在分销和客户参与方面正经历着巨大的变革。电子商务和远端兽医服务正在扩大产品和专业知识的获取管道，尤其是在都市区宠物饲主和地理位置分散的生产者中。分销管道的分散化促使现有企业寻求整合诊断、治疗和咨询服务的一体化解决方案。此外，监管审查的加强和药物安全检测预期的提高，正在推动对上市后监测和证据产生的投资，以支持产品生命週期策略。

最后，永续性和管理方面出现了显着的趋势。将化学、生物和管理干预措施相结合的综合寄生虫管理方案的普及，反映出人们认识到，保持抗寄生虫功效的同时，最大限度地减少环境和残留问题，对于长期有效至关重要。这些变化标誌着该行业从提供商品转向提供增值、以结果为导向的产品。

评估近期关税调整和2025年贸易政策动态如何再形成采购、供应弹性和策略製造决策

2025年关税调整和贸易政策转变的累积影响，促使人们从策略角度重新评估动物寄生虫药的采购、定价和供应连续性。依赖跨境采购原料药和成品製剂的公司正在评估供应商多元化和在岸生产选项，以降低关税波动的风险。同时，采购团队正在重新调整成本模型，以反映额外关税、物流摩擦以及潜在的最终用户转嫁风险，同时探索长期合约和对冲机制，以稳定投入成本。

这些与贸易相关的不利因素正在加速有关区域製造能力和战略库存定位的讨论。企业正在探索本地生产中心和合约製造伙伴关係，以缩短供应链并减轻关税的影响。同时，经销商和零售商正在重新评估其产品组合策略，以平衡进口奢侈品与关税风险较低、补货週期更快的在地采购。

政策变化也影响投资计划，促使企业权衡新製造地的资本需求与关税减免带来的商业性利益。为此，许多企业优先考虑投资组合合理化，并选择性地进行能够提升利润率韧性的创新投资。整体而言，2025年的关税环境凸显了在整个动物寄生虫杀虫剂价值链中更灵活的供应链设计和主动的贸易风险管理的必要性。

深入的细分洞察，以开发治疗配方、交付模式和分销策略，满足不同动物物种和最终用户的需求

有效的市场区隔对于使产品开发和商业策略与不同治疗方案和客户类别的不同需求保持一致至关重要。按类型划分，杀虫剂分为外寄生虫剂、内寄生虫剂和内寄生虫剂，每种药物都需要不同的疗效数据和抗药性管理方案。伴侣动物的配方和给药需要考虑鸟类、猫、犬和爬虫类，而牲畜应用则针对牛、家禽、绵羊/山羊和猪，每种动物都有各自的生产环境和停药考虑。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 越来越多地采用异噁唑啉咀嚼片配方来控制狗的跳蚤和蜱虫
  • 预防性药物过度使用导致犬心丝虫患者大环内酯类药物抗药性的流行
  • 开发局部抗寄生虫联合治疗以治疗马科动物的多寄生虫感染疾病
  • 扩展口服缓释性跳蚤项圈技术，用于猫科动物患者的长期害虫防治
  • 引入数位诊断和远端管理，实现畜牧业精准寄生虫控制
  • 用于控制小反刍动物寄生虫的新型莫昔克丁和埃普利诺克丁製剂的监管核准加快
  • 奈米颗粒载体系统的创新可提高牛体内兽用驱虫药的生物利用度
  • 整合远端医疗平台，对高价值种畜群进行即时监控和有针对性的驱虫

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第 8 章：动物寄生虫杀虫剂市场（按类型）

  • 杀外寄生虫剂
  • Endectocides
  • 体内杀寄生虫剂

9. 动物寄生虫杀虫剂市场（依动物类型）

  • 伴侣动物
    • 鸟
    • 猫
    • 狗
    • 爬虫类
  • 家畜
    • 牛
    • 家禽
    • 绵羊和山羊
    • 猪

第 10 章：动物寄生虫杀虫剂市场（按应用）

  • 注射给药
  • 口服
  • 局部给药

第 11 章：动物寄生虫杀虫剂市场（依寄生虫类型）

  • 绦虫
  • 体外寄生虫
  • 线虫
  • 吸虫

第 12 章动物寄生虫杀虫剂市场（依分销管道）

  • 线下零售
  • 网路零售

第 13 章。动物寄生虫杀虫剂市场（依最终用户）

  • 动物农庄
    • 酪农
    • 家禽养殖场
    • 养猪场
  • 家庭宠物饲主
  • 兽医诊所

第 14 章：动物寄生虫杀虫剂市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 15 章动物寄生虫杀虫剂市场（按类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 16 章：各国动物寄生虫杀虫剂市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • AB Vista Inc.
    • Alltech Inc.
    • Ashish Life Science Pvt Limited
    • Aurora Pharmaceutical, Inc.
    • Bayer AG
    • Bimeda Inc.
    • Bioiberica, SA
    • Boehringer Ingelheim International GmbH
    • Cargill Inc.
    • Ceva Sante Animale
    • Covetrus Inc.
    • Dechra Pharmaceuticals Plc
    • Elanco Animal Health Incorporated
    • Indian Immunologicals Limited
    • Jurox Animal Health Ltd.
    • Merck & Co., Inc.
    • Neogen Corporation
    • Norbrook Laboratories Ltd.
    • PetIQ, LLC
    • Vetaid Animal Health
    • VetGuard Inc.
    • Vetoquinol SA
    • Vetsafe Ltd.
    • Virbac Corporation
    • Zhejiang Hisun Pharmaceutical Co., Ltd.
    • Zoetis Inc.
Product Code: MRR-4103B31E05C8

The Veterinary Parasiticides Market is projected to grow by USD 15.18 billion at a CAGR of 7.98% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 8.21 billion
Estimated Year [2025] USD 8.83 billion
Forecast Year [2032] USD 15.18 billion
CAGR (%) 7.98%

Concise orientation to the contemporary veterinary parasiticides environment shaped by animal health priorities, regulatory rigor, and technological momentum

The global veterinary parasiticides arena stands at the intersection of animal welfare expectations, evolving regulatory standards, and accelerated scientific innovation. Over recent years, stakeholders across companion and production animal sectors have prioritized effective parasite control as a cornerstone of health management, productivity, and One Health stewardship. This emphasis has intensified as pet ownership patterns shift, livestock systems modernize, and awareness grows around zoonotic risks that link animal parasitic burdens to broader public health outcomes.

Investment in next-generation chemistries, biologics, and delivery systems has been matched by greater scrutiny from regulatory bodies and a more sophisticated veterinary community demanding safety, efficacy, and sustainability. Simultaneously, the industry is adapting to supply chain realignments, digital distribution channels, and an expanding role for data-driven veterinary services. These forces combine to create both challenges and opportunities for manufacturers, distributors, and veterinary practitioners aiming to meet rising expectations while navigating cost pressures and resistance management imperatives.

Given this dynamic backdrop, executives and practitioners need a clear, evidence-based synthesis of technological trajectories, regulatory signals, and commercial pathways. A careful appraisal of these factors supports informed decisions about product portfolios, strategic partnerships, and investment in innovation that deliver measurable animal health outcomes and durable competitive advantage.

How technological innovation, distribution evolution, and stewardship pressures are jointly transforming research, commercialization, and lifecycle strategies in parasiticides

Transformative shifts are reshaping the veterinary parasiticide landscape at multiple layers, from discovery platforms to end-user interactions. Advances in molecular biology and target-based screening have accelerated identification of novel modes of action, while formulation science has enabled sustained-release, reduced-dosing, and precision-delivery approaches. These technological innovations are complemented by digital tools that enhance treatment adherence, enable remote monitoring of animal health, and support data-driven resistance surveillance.

Concurrently, the industry is experiencing structural shifts in distribution and customer engagement. Ecommerce and tele-veterinary services have expanded access to products and expertise, especially among urban pet owners and geographically dispersed producers. Fragmentation within distribution channels is prompting incumbent firms to pursue integrated solutions that bundle diagnostic, therapeutic, and advisory services. Moreover, heightened regulatory scrutiny and stronger pharmacovigilance expectations are driving investments in post-market surveillance and evidence generation to support product lifecycle strategies.

Finally, there is a palpable movement toward sustainability and stewardship. Integrated parasite management programs that combine chemical, biological, and management interventions are gaining traction, reflecting an acknowledgment that long-term efficacy depends on preserving antiparasitic effectiveness while minimizing environmental and residue concerns. Together, these shifts indicate an industry transitioning from commodity product supply toward value-added, outcome-oriented offerings.

Assessment of how recent tariff adjustments and trade policy dynamics in 2025 are reshaping sourcing, supply resilience, and strategic manufacturing decisions

The cumulative effect of tariff adjustments and trade policy shifts in 2025 is prompting a strategic reassessment across sourcing, pricing, and supply continuity for veterinary parasiticides. Companies that rely on cross-border procurement of active pharmaceutical ingredients or finished formulations are evaluating supplier diversification and onshoring options to mitigate exposure to tariff volatility. In parallel, procurement teams are recalibrating costing models to reflect additional duties, logistical friction, and potential pass-through to end users, while also seeking long-term agreements and hedging mechanisms to stabilize input costs.

These trade-related headwinds are accelerating conversations about regional manufacturing capacity and strategic inventory positioning. Firms are exploring localized production hubs and contract manufacturing partnerships to shorten supply chains and reduce tariff impacts. At the same time, distributors and retailers are reassessing assortment strategies to balance imported premium products with locally sourced alternatives that present lower tariff risk and faster replenishment cycles.

Policy changes have also influenced investment planning, as companies weigh the capital requirements of new manufacturing footprints against the commercial benefits of tariff mitigation. In response, many organizations are prioritizing portfolio rationalization and selective innovation investments that promise higher margin resilience. Overall, the tariff environment in 2025 has underscored the need for more agile supply chain design and proactive trade risk management across the veterinary parasiticide value chain.

Deep segmentation insights that align therapeutic formulation, delivery mode, and distribution strategies to the diverse needs of animal types and end users

Effective segmentation is critical for aligning product development and commercial strategies with distinct needs across therapeutic and customer categories. Based on Type, the landscape includes ectoparasiticides, endectocides, and endoparasiticides, each requiring differentiated efficacy data and resistance management profiles. Based on Animal Type, stakeholders must address divergent use patterns between companion animals and livestock animals; companion animals require formulations and dosing considerations across birds, cats, dogs, and reptiles, while livestock applications span cattle, poultry, sheep and goats, and swine, each with unique production contexts and withdrawal considerations.

Based on Mode Of Application, the industry must balance preferences and constraints among injectable administration, oral administration, and topical administration, with each mode presenting trade-offs in compliance, pharmacokinetics, and practical administration in field settings. Based on Parasite Type, formulation and surveillance priorities are guided by target parasites such as cestodes, ectoparasites, nematodes, and trematodes, driving the need for combination therapies and diagnostics that can inform targeted interventions. Based on Distribution Channel, the channel mix between offline retail and online retail influences marketing, regulatory compliance, and customer support models. Based on End-User, product positioning must reflect the differing requirements of animal farms, household pet owners, and veterinary hospitals, with the Animal Farms segment further differentiated into dairy farms, poultry farms, and swine farms where operational scale and biosecurity practices affect purchasing decisions.

Taken together, this segmentation framework supports more precise value propositions, tailored evidence packages, and channel strategies that respond to the heterogeneous demands across therapeutic categories and user types.

Regional dynamics and differentiated strategies across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence regulation, distribution, and product adoption

Regional dynamics shape regulatory regimes, distribution infrastructures, and product preferences, requiring nuanced geographic strategies. In the Americas, demand patterns are influenced by mature companion animal markets, well-established veterinary channels, and growing emphasis on integrated parasite control programs; regulatory systems tend to emphasize rigorous efficacy and safety data, and private veterinary networks play a central role in product adoption. In Europe, Middle East & Africa, regulatory harmonization across jurisdictions, heightened environmental scrutiny, and diverse agricultural systems create a mosaic of opportunities and constraints; producers in some regions prioritize residue avoidance and sustainability while others focus on rapid productivity gains.

In Asia-Pacific, rapidly expanding companion animal ownership and intensive livestock production systems are driving strong demand for effective parasiticides, with local manufacturing and generic competitiveness shaping price expectations. Across all regions, digital distribution and telehealth-enabled advisory services are gaining traction, though adoption rates vary with infrastructure and regulatory allowances. Additionally, regional differences in parasite prevalence, climatic factors, and farming practices necessitate tailored product portfolios and region-specific resistance management strategies. These geographic distinctions underscore the importance of adaptive regulatory engagement, regional supply chain design, and culturally appropriate customer education initiatives to maximize uptake and ensure responsible use.

Insights into how leading firms combine innovation, partnerships, and service-oriented commercial models to strengthen competitiveness and stewardship

Leading companies in the veterinary parasiticide space are converging on strategies that emphasize differentiated pipelines, strategic partnerships, and enhanced service offerings. Several organizations are investing in novel chemistries and biologic approaches to address resistance hotspots, while others are prioritizing formulation and delivery innovations that improve adherence and animal welfare. Strategic alliances with contract manufacturers, diagnostic providers, and digital health platforms are increasingly common, enabling faster route-to-market for combination solutions that bundle therapeutics with diagnostic and advisory services.

Competitive positioning is also shaped by investments in regulatory science and post-market evidence generation, as demonstrated safety and longitudinal efficacy data become essential differentiators. Companies that integrate stewardship programs, training for veterinarians and farm managers, and clear residue management guidance are better placed to sustain long-term customer trust. Moreover, commercial models are evolving; players that offer subscription-like services, outcome-based contracts, or integrated farm health packages can capture deeper customer relationships and stabilize revenue streams. Across the landscape, successful firms are those that pair technical excellence with pragmatic commercial execution, thereby aligning innovation with real-world veterinary practice and farm management needs.

Actionable strategic priorities and operational measures that industry leaders should implement to enhance resilience, innovation, and responsible product adoption

Industry leaders should prioritize a set of pragmatic actions to navigate current challenges and seize emerging opportunities. First, invest in diversified supplier networks and regional manufacturing capabilities to reduce exposure to trade disruptions and tariffs while maintaining quality controls. Second, accelerate R&D that targets novel modes of action and improved delivery systems to address resistance and improve compliance, while also expanding post-market evidence programs to demonstrate long-term safety and performance. Third, develop integrated offerings that combine therapeutics with diagnostics, digital monitoring, and advisory services, thereby shifting conversations from single-product sales to holistic animal health outcomes.

Furthermore, leaders should implement clear stewardship and education initiatives aimed at veterinarians, farm managers, and pet owners to promote responsible use and mitigate resistance development. Collaborating on multi-stakeholder surveillance efforts will enhance the evidence base and inform targeted interventions. Commercially, firms must refine channel strategies to balance offline and online retail strengths, while experimenting with subscription models and bundled services to capture recurring revenue. Finally, adopt scenario-based supply chain planning and flexible contracting to reduce tariff and logistical risk, and allocate capital to partnerships and M&A that accelerate access to complementary capabilities and regional market presence.

Transparent and rigorous research methodology combining stakeholder engagement, secondary evidence review, and scenario analysis to validate findings and implications

The research underpinning these insights integrates multiple qualitative and quantitative approaches to ensure rigor and relevance. Primary engagements included structured interviews with veterinarians, farm managers, regulatory specialists, and commercial leaders to capture real-world perspectives on efficacy, adoption barriers, and procurement dynamics. Secondary analysis encompassed peer-reviewed literature, regulatory guidance documents, clinical trial registries, and publicly available corporate disclosures to validate technological trends and regulatory shifts. Additionally, supply chain and trade databases were examined to understand sourcing patterns and tariff exposure, while digital analytics were used to assess consumer engagement and channel evolution.

Methodologically, triangulation across data sources and stakeholder perspectives was used to reduce bias, and findings were stress-tested through scenario analysis to account for tariff volatility and regulatory contingency. Where applicable, case examples illustrate how specific innovations and commercial models have been implemented in practice, and methodological appendices document inclusion criteria, interview protocols, and data provenance for transparency. This layered approach ensures that the conclusions presented are grounded in observable industry behavior and robust stakeholder input.

Concluding synthesis of the prevailing trends that signal a structural shift toward integrated solutions, resilience, and stewardship in parasiticide practice

In summary, the veterinary parasiticide ecosystem is undergoing sustained transformation driven by scientific innovation, changing distribution and consumption patterns, and heightened regulatory and stewardship expectations. These dynamics are fostering a shift from product-centric approaches toward integrated, outcome-focused solutions that pair therapeutics with diagnostics, digital services, and advisory support. Simultaneously, trade policy changes and supply chain complexities are prompting strategic realignment in sourcing and manufacturing decisions, emphasizing resilience and regional adaptability.

For stakeholders across the value chain, the imperative is clear: align R&D, commercial, and operational strategies with evolving end-user needs and regulatory realities. Prioritizing stewardship, investing in differentiated delivery mechanisms, and embracing flexible distribution models will be critical to maintaining efficacy, protecting animal welfare, and unlocking commercial value. Looking ahead, organizations that effectively integrate technical innovation with pragmatic market strategies and robust supply chain planning will be best positioned to lead in a more demanding and opportunity-rich environment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growing adoption of isoxazoline-based chewable formulations for canine flea and tick control
  • 5.2. Rising prevalence of macrocyclic lactone resistance in canine heartworm populations due to prophylactic overuse
  • 5.3. Development of topical endectocide combination therapies to address multi-parasite infestations in equine practice
  • 5.4. Expansion of oral sustained-release flea collar technology for extended pest management in feline patients
  • 5.5. Implementation of digital diagnostics and remote dispensing for precision parasite control in livestock operations
  • 5.6. Regulatory approvals accelerating novel moxidectin and eprinomectin formulations for small ruminant parasite management
  • 5.7. Innovations in nanoparticle carrier systems enhancing bioavailability of veterinary antiparasitic compounds in cattle
  • 5.8. Integration of telemedicine platforms for real-time monitoring and targeted deworming in high-value breeding herds

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Parasiticides Market, by Type

  • 8.1. Ectoparasiticides
  • 8.2. Endectocides
  • 8.3. Endoparasiticides

9. Veterinary Parasiticides Market, by Animal Type

  • 9.1. Companion Animals
    • 9.1.1. Birds
    • 9.1.2. Cats
    • 9.1.3. Dogs
    • 9.1.4. Reptiles
  • 9.2. Livestock Animals
    • 9.2.1. Cattle
    • 9.2.2. Poultry
    • 9.2.3. Sheep & Goats
    • 9.2.4. Swine

10. Veterinary Parasiticides Market, by Mode Of Application

  • 10.1. Injectable Administration
  • 10.2. Oral Administration
  • 10.3. Topical Administration

11. Veterinary Parasiticides Market, by Parasite Type

  • 11.1. Cestodes
  • 11.2. Ectoparasites
  • 11.3. Nemotodes
  • 11.4. Trematodes

12. Veterinary Parasiticides Market, by Distribution Channel

  • 12.1. Offline Retail
  • 12.2. Online Retail

13. Veterinary Parasiticides Market, by End-User

  • 13.1. Animal Farms
    • 13.1.1. Dairy Farms
    • 13.1.2. Poultry Farms
    • 13.1.3. Swine Farms
  • 13.2. Household Pet Owners
  • 13.3. Veterinary Hospitals

14. Veterinary Parasiticides Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Veterinary Parasiticides Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Veterinary Parasiticides Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. AB Vista Inc.
    • 17.3.2. Alltech Inc.
    • 17.3.3. Ashish Life Science Pvt Limited
    • 17.3.4. Aurora Pharmaceutical, Inc.
    • 17.3.5. Bayer AG
    • 17.3.6. Bimeda Inc.
    • 17.3.7. Bioiberica, S.A.
    • 17.3.8. Boehringer Ingelheim International GmbH
    • 17.3.9. Cargill Inc.
    • 17.3.10. Ceva Sante Animale
    • 17.3.11. Covetrus Inc.
    • 17.3.12. Dechra Pharmaceuticals Plc
    • 17.3.13. Elanco Animal Health Incorporated
    • 17.3.14. Indian Immunologicals Limited
    • 17.3.15. Jurox Animal Health Ltd.
    • 17.3.16. Merck & Co., Inc.
    • 17.3.17. Neogen Corporation
    • 17.3.18. Norbrook Laboratories Ltd.
    • 17.3.19. PetIQ, LLC
    • 17.3.20. Vetaid Animal Health
    • 17.3.21. VetGuard Inc.
    • 17.3.22. Vetoquinol S.A.
    • 17.3.23. Vetsafe Ltd.
    • 17.3.24. Virbac Corporation
    • 17.3.25. Zhejiang Hisun Pharmaceutical Co., Ltd.
    • 17.3.26. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY MODE OF APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY MODE OF APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS VETERINARY PARASITICIDES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VETERINARY PARASITICIDES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE VETERINARY PARASITICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST VETERINARY PARASITICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA VETERINARY PARASITICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC VETERINARY PARASITICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN VETERINARY PARASITICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC VETERINARY PARASITICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION VETERINARY PARASITICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS VETERINARY PARASITICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 VETERINARY PARASITICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO VETERINARY PARASITICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. VETERINARY PARASITICIDES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. VETERINARY PARASITICIDES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. VETERINARY PARASITICIDES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ECTOPARASITICIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ECTOPARASITICIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ECTOPARASITICIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ECTOPARASITICIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ENDECTOCIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ENDECTOCIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ENDECTOCIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ENDECTOCIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ENDECTOCIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ENDECTOCIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ENDOPARASITICIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ENDOPARASITICIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ENDOPARASITICIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ENDOPARASITICIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY BIRDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY BIRDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY BIRDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY BIRDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY BIRDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY BIRDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY CATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY CATS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY CATS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY CATS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY CATS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY CATS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY DOGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY DOGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY DOGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY DOGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY DOGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY REPTILES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY REPTILES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY REPTILES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY REPTILES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY REPTILES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY REPTILES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY LIVESTOCK ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY LIVESTOCK ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY LIVESTOCK ANIMALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY LIVESTOCK ANIMALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY LIVESTOCK ANIMALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY LIVESTOCK ANIMALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY LIVESTOCK ANIMALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY POULTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY POULTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY POULTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY POULTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY SHEEP & GOATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY SHEEP & GOATS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY SHEEP & GOATS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY SHEEP & GOATS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY SHEEP & GOATS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY SHEEP & GOATS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY SWINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY SWINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY SWINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY SWINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY MODE OF APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY MODE OF APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY INJECTABLE ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY INJECTABLE ADMINISTRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY INJECTABLE ADMINISTRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY INJECTABLE ADMINISTRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY INJECTABLE ADMINISTRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY INJECTABLE ADMINISTRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ORAL ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ORAL ADMINISTRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ORAL ADMINISTRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ORAL ADMINISTRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ORAL ADMINISTRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ORAL ADMINISTRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY TOPICAL ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY TOPICAL ADMINISTRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY TOPICAL ADMINISTRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY TOPICAL ADMINISTRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY TOPICAL ADMINISTRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY TOPICAL ADMINISTRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY CESTODES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY CESTODES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY CESTODES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY CESTODES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY CESTODES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY CESTODES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ECTOPARASITES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ECTOPARASITES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ECTOPARASITES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ECTOPARASITES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ECTOPARASITES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ECTOPARASITES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY NEMOTODES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY NEMOTODES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY NEMOTODES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY NEMOTODES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY NEMOTODES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY NEMOTODES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY TREMATODES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY TREMATODES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY TREMATODES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY TREMATODES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY TREMATODES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY TREMATODES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY OFFLINE RETAIL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY OFFLINE RETAIL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY OFFLINE RETAIL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY OFFLINE RETAIL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY OFFLINE RETAIL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY OFFLINE RETAIL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL FARMS, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL FARMS, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL FARMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL FARMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL FARMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL FARMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL FARMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL FARMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY DAIRY FARMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY DAIRY FARMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY DAIRY FARMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY DAIRY FARMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY DAIRY FARMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY DAIRY FARMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY POULTRY FARMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY POULTRY FARMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY POULTRY FARMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY POULTRY FARMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY POULTRY FARMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY POULTRY FARMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY SWINE FARMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY SWINE FARMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY SWINE FARMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY SWINE FARMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY SWINE FARMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY SWINE FARMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY HOUSEHOLD PET OWNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY HOUSEHOLD PET OWNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY HOUSEHOLD PET OWNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY HOUSEHOLD PET OWNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY HOUSEHOLD PET OWNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY HOUSEHOLD PET OWNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL VETERINARY PARASITICIDES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS VETERINARY PARASITICIDES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS VETERINARY PARASITICIDES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS VETERINARY PARASITICIDES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS VETERINARY PARASITICIDES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS VETERINARY PARASITICIDES MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS VETERINARY PARASITICIDES MARKET SIZE, BY COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS VETERINARY PARASITICIDES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS VETERINARY PARASITICIDES MARKET SIZE, BY LIVESTOCK ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS VETERINARY PARASITICIDES MARKET SIZE, BY MODE OF APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS VETERINARY PARASITICIDES MARKET SIZE, BY MODE OF APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS VETERINARY PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS VETERINARY PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS VETERINARY PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS VETERINARY PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS VETERINARY PARASITICIDES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS VETERINARY PARASITICIDES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL FARMS, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL FARMS, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY LIVESTOCK ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY MODE OF APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY MODE OF APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL FARMS, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL FARMS, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. LATIN AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY LIVESTOCK ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY MODE OF APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY MODE OF APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL FARMS, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL FARMS, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA VETERINARY PARASITICIDES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA VETERINARY PARASITICIDES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA VETERINARY PARASITICIDES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA VETERINARY PARASITICIDES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA VETERINARY PARASITICIDES MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA VETERINARY PARASITICIDES MARKET SIZE, BY COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA VETERINARY PARASITICIDES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA VETERINARY PARASITICIDES MARKET SIZE, BY LIVESTOCK ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA VETERINARY PARASITICIDES MARKET SIZE, BY MODE OF APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA VETERINARY PARASITICIDES MARKET SIZE, BY MODE OF APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA VETERINARY PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA VETERINARY PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA VETERINARY PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA VETERINARY PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA VETERINARY PARASITICIDES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA VETERINARY PARASITICIDES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL FARMS, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL FARMS, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE VETERINARY PARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE VETERINARY PARASITICIDES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE VETERINARY PARASITICIDES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE VETERINARY PARASITICIDES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE VETERINARY PARASITICIDES MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE VETERINARY PARASITICIDES MARKET SIZE, BY COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE VETERINARY PARASITICIDES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE VETERINARY PARASITICIDES MARKET SIZE, BY LIVESTOCK ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE VETERINARY PARASITICIDES MARKET SIZE, BY MODE OF APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE VETERINARY PARASITICIDES MARKET SIZE, BY MODE OF APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE VETERINARY PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE VETERINARY PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE VETERINARY PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE VETERINARY PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE VETERINARY PARASITICIDES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE VETERINARY PARASITICIDES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL FARMS, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL FARMS, 2025-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST VETERINARY PARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. MIDDLE EAST VETERINARY PARASITICIDES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST VETERINARY PARASITICIDES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. MIDDLE EAST VETERINARY PARASITICIDES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. MIDDLE EAST VETERINARY PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST VETERINARY PARASITICIDES MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 300. MIDDLE EAST VETERINARY PARASITICIDES MARKET SIZE, BY COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST VETERINARY PARASITICIDES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 302. MIDDLE EAST VETERINARY PARASITICIDES MARKET SIZE, BY LIVESTOCK ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 303. MIDDLE EAST VETERINARY PARASITICIDES MARKET SIZE, BY MODE OF APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 304. MIDDLE EAST VETERINARY PARASITICIDES MARKET SIZE, BY MODE OF APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 305. MIDDLE EAST VETERINARY PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. MIDDLE EAST VETERINARY PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2025-2032 (USD MILLION)
  • TABLE 307. MIDDLE EAST VETERINARY PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 308. MIDDLE EAST VETERINARY PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 309. MIDDLE EAST VETERINARY PARASITICIDES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 310. MIDDLE EAST VETERINARY PARASITICIDES MARKET SIZE, BY END-USER, 2025-2032 (USD MILL